NanoGroup S.A.
Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.
NNG | WAR
Overview
Corporate Details
- ISIN(s):
- PLNNGRP00011 (+3 more)
- LEI:
- 259400HXWEAZUWRLY648
- Country:
- Poland
- Address:
- Warszawa Rakowiecka 36, 02-532 Warszawa
- Website:
- https://en.nanogroup.eu/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NanoGroup S.A. is a biotechnology company that develops and commercializes innovative medical solutions based on its unique, patented nanotechnology. The group's research and development work is concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key projects include the development of nanoformulations for anticancer drugs, a fluid for the storage of organs intended for transplantation, nanoparticles for diagnostics and therapy, and a human blood substitute. The company operates through specialized subsidiaries, such as nanoSanguis and nanoVelos, to advance its distinct technological platforms and bring new medical technologies to market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-06 12:47 |
Board/Management Information
Oświadczenie
|
Polish | 131.2 KB | ||
| 2025-10-06 12:47 |
Board/Management Information
Życiorys
|
English | 199.3 KB | ||
| 2025-10-06 12:47 |
Board/Management Information
Zgłoszenie kandydata na Członka Rady Nadzorczej NANOGROUP S.A. - Content (PL)
|
Polish | 780 bytes | ||
| 2025-10-01 17:02 |
Related Party Transaction
Powiadomienie
|
Polish | 4.4 KB | ||
| 2025-10-01 17:02 |
Major Shareholding Notification
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 545 bytes | ||
| 2025-10-01 16:53 |
Director's Dealing
Powiadomienie
|
Polish | 4.3 KB | ||
| 2025-10-01 16:53 |
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 469 bytes | ||
| 2025-09-25 18:33 |
Audit Report / Information
Raport audytora
|
Polish | 647.6 KB | ||
| 2025-09-25 18:33 |
Interim Report
Sprawozdanie
|
Polish | 1.1 MB | ||
| 2025-09-25 18:23 |
Audit Report / Information
Opinia Rady Nadzorczej
|
Polish | 56.6 KB | ||
| 2025-09-25 18:23 |
Management Discussion and Analysis
Stanowisko Zarządu
|
Polish | 325.8 KB | ||
| 2025-09-25 18:23 |
Audit Report / Information
Raport audytora
|
Polish | 636.8 KB | ||
| 2025-09-25 18:23 |
Interim Report
Sprawozdanie
|
Polish | 1.1 MB | ||
| 2025-09-24 10:52 |
Regulatory News Service
Uzyskanie przez spółkę zależną od NanoGroup S.A. patentu na podstawie konwencji…
|
Polish | 3.0 KB | ||
| 2025-09-23 14:40 |
Regulatory News Service
Uzyskanie przez spółkę zależną od NanoGroup S.A. patentu w Korei Południowej - …
|
Polish | 2.0 KB |
Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
